Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adultsJackson, Sam ; Lentino, Joseph ; Kopp, James ; Murray, Linda ; Ellison, William ; Rhee, Margaret ; Shockey, Gerald ; Akella, Lalith ; Erby, Kimberly ; Heyward, William L. ; Janssen, Robert S. ; Adams, Michael ; Bolshoun, David ; Bruce, Tami ; Chuang, Rita ; DeSantis, Donna ; Fiel, Thomas ; Fitzgibbons, William ; Francyk, David ; Geisberg, Harry ; Giep, Son ; Godbole, Narendra ; Haas, Terry ; Halpern, Stephen ; Inzerello, Anthony ; Jennings, William ; Kaiser, Scott ; Kay, Jennifer ; Kirby, William ; Lending, Robert ; Levins, Peter ; Molin, Clifford ; Noss, Michael ; Kotek, Larry ; Reynolds, Michele ; Riffer, Ernie ; Schumacher, Douglas ; Severance, Randall ; Solano, Royce ; Tejada, Albert ; Tharenos, Leslie ; Throne, Martin ; Turner, Merle ; Wolf, Thomas ; Woodruff, MarkVaccine, 2018-01, Vol.36 (5), p.668-674 [Periódico revisado por pares]Netherlands: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Mivavotinib, a Syk Inhibitor, in Relapsed/Refractory (R/R) Non-GCB Diffuse Large B-Cell Lymphoma (DLBCL) with or without MYD88 and/or CD79 Mutations: A Phase 2 StudyKarmali, Reem ; Landsburg, Daniel J. ; Westin, Jason ; Leonard, John P. ; Kuriakose, Emil T. ; Sumrow, Bradley James ; Carroll, Susheela ; Albert, Katherine ; Akella, Lalith ; Gordon, Leo I.Blood, 2022-11, Vol.140 (Supplement 1), p.12125-12126 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
3 |
Material Type: Artigo
|
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA TrialLee, Chung-Han ; Motzer, Robert ; Emamekhoo, Hamid ; Matrana, Marc ; Percent, Ivor ; Hsieh, James J ; Hussain, Arif ; Vaishampayan, Ulka ; Liu, Sandy ; McCune, Steven ; Patel, Vijay ; Shaheen, Montaser ; Bendell, Johanna ; Fan, Alice C ; Gartrell, Benjamin A ; Goodman, Oscar B ; Nikolinakos, Petros G ; Kalebasty, Arash Rezazadeh ; Zakharia, Yousef ; Zhang, Zhentao ; Parmar, Hema ; Akella, Lalith ; Orford, Keith ; Tannir, Nizar MClinical cancer research, 2022-08, Vol.28 (15), p.3248-3255 [Periódico revisado por pares]United StatesTexto completo disponível |
|
4 |
Material Type: Artigo
|
Telaglenastat Plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 ENTRATA TrialLee, Chung-Han ; Motzer, Robert ; Emamekhoo, Hamid ; Matrana, Marc ; Percent, Ivor ; Hsieh, James J. ; Hussain, Arif ; Vaishampayan, Ulka ; Liu, Sandy ; McCune, Steven ; Patel, Vijay ; Shaheen, Montaser ; Bendell, Johanna ; Fan, Alice C. ; Gartrell, Benjamin A. ; Goodman, Oscar B. ; Nikolinakos, Petros G. ; Kalebasty, Arash Rezazadeh ; Zakharia, Yousef ; Zhang, Zhentao ; Parmar, Hema ; Akella, Lalith ; Orford, Keith ; Tannir, Nizar M.Clinical cancer research, 2022-08, Vol.28 (15), p.3248-3255 [Periódico revisado por pares]Texto completo disponível |
|
5 |
Material Type: Artigo
|
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical TrialTannir, Nizar M ; Agarwal, Neeraj ; Porta, Camillo ; Lawrence, Nicola J ; Motzer, Robert ; McGregor, Bradley ; Lee, Richard J ; Jain, Rohit K ; Davis, Nancy ; Appleman, Leonard J ; Goodman, Oscar ; Stadler, Walter M ; Gandhi, Sunil ; Geynisman, Daniel M ; Iacovelli, Roberto ; Mellado, Begoña ; Sepúlveda Sánchez, Juan Manuel ; Figlin, Robert ; Powles, Thomas ; Akella, Lalith ; Orford, Keith ; Escudier, BernardJAMA oncology, 2022-10, Vol.8 (10), p.1411-1418 [Periódico revisado por pares]American Medical AssociationTexto completo disponível |
|
6 |
Material Type: Artigo
|
CANTATA: Primary analysis of a global, randomized, placebo (Pbo)-controlled, double-blind trial of telaglenastat (CB-839) + cabozantinib versus Pbo + cabozantinib in advanced/metastatic renal cell carcinoma (mRCC) patients (pts) who progressed on immune checkpoint inhibitor (ICI) or anti-angiogenic therapiesTannir, Nizar M. ; Agarwal, Neeraj ; Porta, Camillo ; Lawrence, Nicola Jane ; Motzer, Robert J. ; Lee, Richard J. ; Jain, Rohit K. ; Davis, Nancy B. ; Appleman, Leonard Joseph ; Goodman, Oscar B. ; Stadler, Walter Michael ; Gandhi, Sunil G. ; Geynisman, Daniel M. ; Iacovelli, Roberto ; Mellado, Begona ; Figlin, Robert A. ; Powles, Thomas ; Akella, Lalith V ; Orford, Keith W. ; Escudier, BernardJournal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4501-4501 [Periódico revisado por pares]Texto completo disponível |
|
7 |
Material Type: Artigo
|
Immunogenicity of Investigational 2-Dose Hepatitis B Vaccine, HEPLISAV-B, Compared With a Licensed Vaccine (ENGERIX-B) in Adults With Factors That Reduce Immune ResponsesJackson, Sam ; Erby, Kim ; Akella, Lalith ; Heyward, William L. ; Hyer, Randy ; Janssen, RobertOpen forum infectious diseases, 2016-12, Vol.3 (suppl_1) [Periódico revisado por pares]Texto completo disponível |
|
8 |
Material Type: Artigo
|
PL2: Towards Predictable Low Latency in Rack-Scale NetworksLe, Yanfang ; Radhika Niranjan Mysore ; Suresh, Lalith ; Zellweger, Gerd ; Banerjee, Sujata ; Akella, Aditya ; Swift, MichaelarXiv.org, 2021-01Ithaca: Cornell University Library, arXiv.orgTexto completo disponível |